Director, Development and Public Affairs
New York, NY - June 1, 2008
The Rogosin Institute's Transplantation Program at NewYork-Presbyterian/Weill Cornell began the areas first three-way living-donor kidney transplant chains in February 2008 followed by a double donor exchange kidney transplant in May 2008.
More than 70 centers refer patients to The Rogosin Institute's Transplantation Program at NewYork-Presbyterian/Weill Cornell. The transplant outreach program is expanding to other areas and centers.
The Rogosin Institute's Transplantation Center at NewYork-Presbyterian/Weill Cornell celebrated it's 3,000th kidney transplant in 2007.
The Rogosin Kidney Center is one of the largest not-for-profit dialysis centers. Rogosin's three dialysis centers perform 100,000 dialyses/year and provide care for more than 700 patients.
The Rogosin Kidney Center is proud to be a major contributor to the #2 ranking nationwide of NewYork-Presbyterian Hospital in kidney disease by U.S. News &World Report.
The Rogosin Institute's Polycystic Kidney Disease Center is one of the only centers in the metropolitan area for the treatment and research of polycystic kidney disease. Referrals to the center are increasing.
The Rogosin Institute's Comprehensive Lipid Control Center follows over 5,000 patients and is considered one of few preeminent research and treatment programs focused on cholesterol control.
The Rogosin Institute continues to provide LDL-apheresis treatments for patients with familial hypercholesterolemia for which there is no other available treatment. This therapy was developed at Rogosin and is now used at other centers around the world.
The Rogosin Institute developed a novel cancer therapy with successful completion of a 15-patient Phase 1 clinical trial. It is anticipated that Phase 2 will begin this summer.
The Dreyfus Health Foundation, a division of The Rogosin Institute, has helped over six million people in more than 30 countries by challenging them to take action to solve health and social issues affecting their communities.